Association of matrix metalloproteinase-7A-181G variants with the risk of multiple sclerosis

Area of Science:

• Genetics
• Neurology
• Immunology

Background:

• Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
• Genetic factors play a role in MS susceptibility and disease progression.
• Matrix metalloproteinases (MMPs) are involved in extracellular matrix remodeling and inflammation, potentially influencing MS pathogenesis.

Purpose of the Study:

• To investigate the association between the matrix metalloproteinase-7 (MMP-7) A-181G polymorphism and the risk of developing multiple sclerosis (MS).
• To examine the influence of this MMP-7 variant on neurological disability in MS patients.

Main Methods:

• A case-control study was conducted involving 126 MS patients and 190 healthy controls.
• Genotyping was performed to analyze the MMP-7 A-181G variants.
• Clinical data, including age at onset and Expanded Disability Status Scale (EDSS) scores, were collected.

Main Results:

• The MMP-7 G allele and AG+GG genotype were significantly associated with an increased risk of MS in females (OR=1.59, p=0.011).
• Patients with disease onset at or before 19 years showed a markedly higher risk with the MMP-7 G allele (OR=8.77, p=0.038).
• In secondary progressive MS, carriers of the AG genotype exhibited higher mean EDSS scores (4.9 ± 0.85) compared to AA genotype carriers (3.75 ± 0.41).

Conclusions:

• The MMP-7 A-181G polymorphism may contribute to MS susceptibility, particularly in females and those with early disease onset.
• This genetic variant is potentially associated with increased neurological disability in patients with secondary progressive MS.
• Further research is warranted to elucidate the functional mechanisms linking MMP-7 variants to MS pathogenesis and progression.